Disposable Medical Sensors Market Value Chain and Forecast 2015-2025

Disposable medical sensors are portable scanning devices intended for diagnosis, patient monitoring and therapeutic processes. Disposable medical sensors are designed to detect and provide information in the form of electrical signals by converting patient’s various forms of stimulations. Disposable medical sensors facilitate continuous patient monitoring through the measurement of basic vital signs, for instance heart rate, breathing rate, blood oxygenation level, pulse rate and temperature. Disposable medical sensors are used in different specialties such as cardiology, radiology, general medicine, neurology, ophthalmology, urology and so on. Currently the trend witnessed in the global disposable medical sensors market is the development of products in ablation treatments for cancer, cardiac arrhythmia, point of care diagnosis, pain free glucose monitoring, wireless insulin delivering procedures, etc.

Disposable Medical Sensors Market: Drivers and Restraints

Disposable medical sensors market is projected to grow rapidly due to increasing incidence of chronic diseases such as cancer, acute myocardial infarction and diabetes mellitus particularly in geriatric population, as well as increasing number of postoperative rehabilitation patients across the globe. Major drivers for the disposable medical sensors market are technological advancements and increasing innovations in the development of point of care medical sensors for diagnosis and monitoring outside hospitals. At the same time increasing the need of remote patient monitoring and next generation disposable medical sensors such as painless diabetes monitors, wearable wrist watches, etc. are other opportunities to manufacturers. Large number of regulatory approvals for biodegradable sensors are also booming the global disposable medical sensors market. However lack of adequate reimbursement policies for novel technologies and stringent regulatory procedures are the major factors that can hamper the global disposable medical sensors growth over the forecast period.

Disposable Medical Sensors Market: Segmentation

The global disposable medical sensors market has been classified on the basis of application, placement type, type of sensors, end user and region.

Based on application, the global disposable medical sensors market is segmented into the following:

  • Patient monitoring
    • Continuous Blood Pressure Monitoring
    • Implantable Loop Recorder
    • Cardiac Monitoring Electrode
    • Pulse Oximeter
    • Smart Pill
    • Continuous Blood Glucose Monitoring
  • Diagnostics
    • Capsule Endoscopes
    • HIV Test Strip Sensors
    • Pregnancy Test Strip Sensors
    • Drug And Alcohol Test Strip Sensors
    • Blood Glucose Test Strip Sensors
    • Immunoassay Biosensors
  • Therapeutics
    • Insulin Pump Sensors
    • Dialysis Sensors
    • Cardiac Therapeutic Electrode Sensors
    • Cardiac Catheter Sensors

Based on Placement Type, the global disposable medical sensors market is segmented into the following:

  • Implantable sensors
  • Invasive sensors
  • Ingestible sensors
  • Strip sensors
  • Wearable sensors

Based on Type of Sensors, the global disposable medical sensors market is segmented into the following:

  • Biosensors
  • Accelerometers
  • Image sensors
  • Pressure sensors
  • Temperature sensors
  • MR Position Sensors
  • Force Sensors
  • Humidity Sensors

Based on End User, the global disposable medical sensors market is segmented into the following:

  • Hospitals
  • Home Care
  • Diagnostic Laboratories
  • Clinics

Disposable Medical Sensors Market: Overview

The United States represents the largest market for disposable medical device sensors in North America, followed by Canada. Europe is expected to be the second largest region in the global disposable medical sensors market. Germany, France, and the U.K. are estimated to account for a major share in the Europe disposable medical sensors market over the forecast period. APAC is anticipated to represent a high growth rate in the next five years. By application type, monitoring devices particularly cardiac pacemakers and blood glucose monitorsare the dominant segment across globe due to high incidences of diabetes and cardiac diseases. The diagnostic strips for HIV test, pregnancy test, blood glucose test and immunological test are anticipated to hold a high collective share in the global disposable medical sensors market. By end use, the hospitals and home care segments are projected to account for around 50% share in the global disposable medical sensors market and the trend is forecast to continue through the forecast period. By placement of sensors type, wearable sensors and strip sensors are estimated to register above average CAGR over the forecast period owing to its affordable price due to miniaturization of equipment.

This New At-Home Fertility Test Is Perfect for People Who Want Kids—But Not Today

I am a 31-year-old woman who is married and living in New York City, and I definitely want kids one day. I grew up in a large family just outside of Chicago, and almost all of my high school friends are married with children. But I have spent the past decade prioritizing my career as a magazine editor, something I’m still trying to establish before my prime midnight-oil-burning years are up. At which point, I’ll start thinking about a family—exact time to be determined.

It’s a certain type of drive that runs rampant in my cohort of working millennial women: rise up in your career first, consider the mind/body/wellness/fertile factor second (or third, as evidenced by last year’s number of births, which hit an all-time low since 1987, especially among those in their 30s). And while I can imagine the working mom scene perfectly—me, donning a cutting-edge breast pump under my Off-White suit, taking calls or making edits with my office door closed (Note to self: Must get office before I get pregnant)—the reality of how many eggs I’ll have left in my basket at that time may be a lot less glamorous.

Nevertheless, it’s a thought I felt comfortable designating for “later’—until this summer, when an email about an affordable at-home fertility test that measures your reproductive hormones and tells you things like when you can expect to go through menopause hit my inbox. A deadline? Deadlines I can do.

Called Modern Fertility, it’s a startup that, in addition to testing for nine hormones (including your anti-Mullerian hormone, follicle-stimulating hormone, and luteinizing hormone—which is also tracked in over-the-counter ovulation predictor tests), aims to arm women with knowledge surrounding their reproductive health so they can one day consider such options as egg freezing and in vitro fertilization should they need to, and before it’s too late.

“People talk about infertility all the time,” says Afton Vechery, the company’s cofounder and CEO, who spent time at 23andMe, as well as a private equity firm, where she often worked with fertility clinics and got a first look at how inopportune and costly in-office reproductive testing can be for some individuals. “But people rarely talk about fertility. That’s what we’re interested in.”

It’s an empowering thought—my fertility versus my infertility, and for a fraction of the cost—and one that doesn’t feel intimidating nor too far away. I can do this, I thought, as I opened up the all-white box filled with two finger-testing pricks on the morning of my third day of my period (an important time stamp, as hormone levels fluctuate throughout your monthly cycle). Not one for blood, I felt surprisingly at ease when poking my finger twice and sealing my test strips in the postage-marked packaging, all from the privacy of my living room couch.

And yet it’s precisely that DIY collection method, now increasingly popular among consumers seeking everything from personalized fitness recommendations via a DNA kit to HIV screening results, that worries some experts. Taken out of context, fertility results may prove particularly murky. “If anything comes back out of the average or normal parameters, it may cause unnecessary angst,” says Alexis Greene, M.D., a reproductive endocrinologist and fertility specialist at Westmed Medical Group in Westchester, New York, who sees numerous women struggling with their fertility as well as reproductive disorders, like irregular periods or polycystic ovary syndrome (PCOS). “Fertility is not just numbers; it’s a big spectrum that encompasses a lot of different things beyond lab work, such as age, prior history, if you’ve ever been pregnant before, and what your ovaries look like on an ultrasound.”

And while Modern Fertility doesn’t offer a way to see how many follicles you have in your ovarian reserve, let alone actual medical advice—though its staff of nurses will walk you through your results and help you link up with a specialist should anything come back abnormal—the company attempts to do its due diligence by asking your age, prior diagnoses, whether you’re taking birth control, and how regular your periods are before looking at you from a hormonal perspective.

Less than a week after sending in my test, I received an email with the subject line “Your Modern report is ready” and a link to my results as well as an invite to a private webinar with Jill, the company’s fertility nurse. With a huge pit in my stomach, I double clicked the provided link and opened onto a page that stated my ovarian reserve, ovulation, and general body hormone levels. A rush of heat hit my ears when I read that I was, almost across the board, average.

Average? Average to my type A mind is below average; not excellent; doomed; dried up; dusty; Jan versus Marcia Brady! I speed-read through the results: I have an average number of eggs for my age; I may hit menopause around the average age; I may collect an average amount of eggs in IVF or egg freezing; “Your Free thyroxine (fT4) is outside of the normal range. Not to worry, your doctor can help balance things out.” I shut the computer and avoided setting up a call with Jill for another two days.

“While many of us are seeking excellence in everything we do, in reproductive health, average is normal, and normal is good—that’s where you want to be,” says Jill Kerwin, R.N., B.S.N., a certified holistic nurse who struggled with infertility herself and ended up having two children with the help of IVF and a donor.

And then, just as I’m starting to feel slightly better, she adds: “That said, the sooner you have kids, from a reproductive perspective, the better, because you’re losing eggs, aging, and being exposed to more toxins every single day.” She suggested I start conversations with my ob-gyn, and perhaps ask for an additional thyroid ultrasound, as low levels of fT4, which helps the body expand energy, may get in the way of fertility down the line. (Cue the unnecessary angst . . . now.)

Take it with a grain of salt, urges Shannon Tomita, a fellow in gynecologic oncology at Mount Sinai Hospital who, while agreeing with Greene that fertility is a lot more complicated than a few blood tests, sees the positive side to a test like this, too. “Anything that makes women be more proactive and less reactive, and gets them in to see their doctor, is a good thing. Because there is really no substitute to seeing someone who can talk to you directly about all the questions you may have.”

Currently on the hunt for an ob-gyn who my husband and I see in our fertility future, so we can speak and perhaps act on my results, our exact timeline is still to be determined—but there’s at least one major change worth noting: I now officially answer that common question with, “Yes, we’re trying.” And it feels pretty empowering.

Banker stabs his 29-year old wife 45 times, wrongly thinking she gave him HIV, but only got to 25 years in prison

He killed her because he thought she infected him with HIV, he coerced his 5-year old daughter to help clean her mother’s blood. It turns out she was HIV-negative.

Banker thinks his wife gave him HIV, so he stabs her 45 times

This October, Khazamula Emmanuel Baloyi was only sentenced to 25 years in prison by the Gauteng High Court, Pretoria in the matter of the State v Baloyi (CC168/17) [2018] ZAGPPHC 19 despite stabbing his wife all over her body in January 2017.

Their 5-year old daughter, Amukelani helped clean her mother’s blood and saw her mother’s body.

Baloyi had been diagnosed with AIDS some days earlier, so he went home and accused his wife of infecting him with the disease, he also accused her of infidelity.

Post-mortem results show that she was in fact HIV-negative. She was only 29 when she died.

According to court documents of the Gauteng High Court, the messy background story

Mr. Baloyi and the deceased (his wife) met each other during January 2010 and subsequently got married on 28 November 2015. At that stage, both were employed. Mr. Baloyi was employed by ABSA Bank and the deceased was a qualified nursing sister at Steve Biko Hospital.

The deceased got pregnant and the family started the lobola negotiations — payment of bride price — during September 2011. On December 8, 2012, a ceremony to celebrate the completion of lobola negotiations and payment was held in Limpopo.

They lived together since 2011 and decided to have their white wedding on November 28, 2015.

They were married for approximately 15 (fifteen) months before Mr. Baloyi murdered his wife in January 2017. Mr. Baloyi has two daughters called Amukelani Baloyi, born on October 24, 2011, and Nkateko Maphuti Baloyi born in June 2014 and that both have been in the care of their maternal grandmother since January 7, 2017.

Mr. Baloyi told a social worker, Mrs. J.C. Wolmarans, who compiled a Psycho Social Pre-Sentence Report and also testified in court that the relationship has been under strain since they moved in together.

The witness then listed certain events to substantiate such strain in the marriage

Mrs. Wolmarans states that during 2012, Mr. Baloyi was employed by ABSA Bank. The conflict in their relationship affected his concentration and he was referred to counseling by his supervisor. Notwithstanding this setback, the families with the couple had a ceremony of welcoming in Limpopo.

During 2013, Mr. Baloyi struggled at his workplace, as he struggled to concentrate. He resigned at the end of October 2013, as he feared that he might be dismissed.

During 2014, the family experienced a few setbacks; a broken down vehicle, housebreaking and the deceased (Mrs. Baloyi) had surgery. Mr. Baloyi described this period as the best time of his marriage.

During 2015, they got married and it was also a happy time until two weeks after the marriage when the deceased and both children went to her family.

During 2016, the deceased entered a three-year course and attended class at night. This apparently led to the relationship deteriorating and subsequently to Mr. Baloyi filing for a divorce. Then, Mr. Baloyi was requested by both families not to proceed with the divorce.

Nigeria Has Second Largest Global Burden Of HIV/AIDS – UNICEF

An Assistant Director and Head of Prevention of Mother To Child Transmission of the United Nations Children’s Fund in Nigeria, Dr. Ijaodola Olugbenga, has stated that Nigeria is the second largest country with the HIV virus in the world.
Olugbenga stated this on Monday during the first day of a two-day media dialogue on PMTCT in Calabar, Cross River State.
He said of the global burden of children living with HIV, Nigeria accounts for 12.4 per cent, which is estimated at 267,000, according to a UNAIDS 2017 report.
He, however, reiterated that Nigeria is committed to the goal of eliminating the mother to child transmission by 2020 and has initiated a number of policies and strategies to reduce the impact.
Olugbenga also noted that nine million women in Nigeria are estimated to be pregnant in the country per year, based on fertility rate and population, and out of that figure, only 40 per cent of them make use of established health facilities and mothers who already have the virus give birth to 8.4 per cent of children with the virus in the country.
He also decried the issue of stigmatization,
He said stigmatization kills more than the virus itself.
Earlier, the Minister of Information and Culture, Alhaji Lai Mohammed, enjoined the media to champion the cause of children to live free of the virus.
The Minister, who was represented by Olumide Osanyipeju, Head, Child Rights Information Bureau of the Ministry, said the Federal Government is on track to bring health services to every child since a large number of children are exposed to the virus.
The Eagle Online reports that the programme is a two-day media dialogue on prevention of mother to child transmission for the training of media practitioners.

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2021: Global Market Size, Competitive Landscape, Key Country Analysis

Human Immunodeficiency Virus (HIV) Rapid Test Kits

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market report analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios. Human Immunodeficiency Virus (HIV) Rapid Test Kits Market also provides historical & futuristic cost, revenue, demand and supply data, business strategies, growth analysis.

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market giving the detailed analysis of the driving factors, trends, challenges met by vendors, regional analysis, segment by type, applications of whole industry. Experts forecast the Human Immunodeficiency Virus (HIV) Rapid Test Kits industry to grow at a CAGR of 7.23% between 2017 to 2021.

Key Vendors in Human Immunodeficiency Virus (HIV) Rapid Test Kits Market: INSTI , F Hoffmann-La Roche, Alere, Abbott, AccuBioTech, Access Bio, Ameritek, ALLDIAG, Atomo Diagnostics, Autobio Diagnostics, Beckman Coulterand many more.

Questions Answered in Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Report: –

  • What are the key factors driving, Analysis by Applications and Countries Human Immunodeficiency Virus (HIV) Rapid Test Kits Market?
  • What are Dynamics, This Overview Includes Analysis of Scope, and price analysis of top Vendors Profiles of Human Immunodeficiency Virus (HIV) Rapid Test Kits?
  • Who are the opportunities and threats faced by the vendors in Human Immunodeficiency Virus (HIV) Rapid Test Kits space? Business Overview by Type, Applications, Gross Margin and Market Share
  • Who are Opportunities, Risk and Driving Force of Human Immunodeficiency Virus (HIV) Rapid Test Kits Market? Knows Upstream Raw Materials Sourcing and Downstream Buyers
  • What will the market growth rate, Overview, and Analysis by Type of Market in 2021?
  • What are the Human Immunodeficiency Virus (HIV) Rapid Test Kits market opportunities, market risk and market overview of the Market?

List of Exhibits in Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Report:

  • Exhibit 01: Product offerings
  • Exhibit 02: Impact of drivers
  • Exhibit 03: Impact of drivers and challenges
  • Exhibit 04: Key countries in each region
  • Exhibit 05: Market shares by geographies 2017
  • Exhibit 06: Human Immunodeficiency Virus (HIV) Rapid Test Kits Market shares by geographies 2021
  • Exhibit 07: Geographical Segmentation by revenue 2017